5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.08▼ | 0.08▲ | 0.08▲ | 0.08▲ | 0.07▲ |
MA10 | 0.08▼ | 0.08▲ | 0.08▲ | 0.07▲ | 0.12▼ |
MA20 | 0.08▲ | 0.07▲ | 0.08▲ | 0.07▲ | 0.32▼ |
MA50 | 0.08▲ | 0.07▲ | 0.07▲ | 0.14▼ | 3.03▼ |
MA100 | 0.07▲ | 0.07▲ | 0.07▲ | 0.34▼ | N/A |
MA200 | 0.07▲ | 0.07▲ | 0.08▲ | 2.97▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.001▲ | 0.001▲ | 0.010▲ | 0.161▲ |
RSI | 55.292▲ | 56.886▲ | 57.763▲ | 39.757▼ | 31.660▼ |
STOCH | 65.333 | 84.554▲ | 83.359▲ | 72.933 | 3.901▼ |
WILL %R | -53.333 | -19.704▲ | -19.704▲ | -28.947 | -97.172▼ |
CCI | 12.505 | 88.827 | 88.205 | 137.201▲ | -63.196 |
Wednesday, April 30, 2025 03:21 PM
Onconetix, Inc. (Nasdaq: ONCO) (the "Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market ("Nasdaq”) on April 24, 2025 indicating that the Company's failure to ...
|
Tuesday, April 29, 2025 04:59 PM
CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex ...
|
Sunday, April 27, 2025 05:00 PM
CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.073 | 0.084 | 0.069 | 0.078 | 20,087,500 |
30/04/25 | 0.073 | 0.0758 | 0.0635 | 0.0731 | 4,904,997 |
29/04/25 | 0.0651 | 0.0836 | 0.0603 | 0.075 | 25,469,472 |
28/04/25 | 0.073 | 0.089 | 0.066 | 0.08 | 26,763,000 |
25/04/25 | 0.069 | 0.071 | 0.051 | 0.07 | 3,859,800 |
24/04/25 | 0.065 | 0.07 | 0.062 | 0.069 | 3,301,600 |
23/04/25 | 0.06 | 0.069 | 0.06 | 0.067 | 7,563,900 |
22/04/25 | 0.055 | 0.061 | 0.054 | 0.059 | 6,698,400 |
21/04/25 | 0.055 | 0.058 | 0.052 | 0.054 | 2,642,800 |
17/04/25 | 0.059 | 0.062 | 0.057 | 0.06 | 1,192,000 |
|
|
||||
|
|
||||
|
|